1 序文
2 範囲および方法論
2.1 本調査の目的
2.2 利害関係者
2.3 データソース
2.3.1 一次情報源
2.3.2 二次情報源
2.4 市場推定
2.4.1 ボトムアップ・アプローチ
2.4.2 トップダウン・アプローチ
2.5 予測方法論
3 エグゼクティブサマリー
4 はじめに
4.1 概要
4.2 主な業界動向
5 世界の骨移植＆代替品市場
5.1 市場概要
5.2 市場実績
5.3 COVID-19 の影響
5.4 材料タイプ別市場内訳
5.5 用途別市場内訳
5.6 エンドユーザー別市場内訳
5.7 地域別市場内訳
5.8 市場予測
6 材料タイプ別市場内訳
6.1 同種移植
6.1.1 市場動向
6.1.2 種類別市場内訳
6.1.2.1 加工同種移植骨
6.1.2.1.1 市場動向
6.1.2.1.2 市場予測
6.1.2.2 脱灰骨マトリックス（DBM）
6.1.2.2.1 市場動向
6.1.2.2.2 市場予測
6.1.3 市場予測
6.2 骨移植代替品
6.2.1 市場動向
6.2.2 種類別市場規模
6.2.2.1 骨形成タンパク質（BMPs）
6.2.2.1.1 市場動向
6.2.2.1.2 市場予測
6.1.2.2 合成骨移植
6.2.2.2.1 市場動向
6.2.2.2.2 市場予測
6.2.3 市場予測
6.3 細胞ベースのマトリックス
6.3.1 市場動向
6.3.2 市場予測
6.4 その他
6.4.1 市場動向
6.4.2 市場予測
7 用途別市場内訳
7.1 脊椎固定術
7.1.1 市場動向
7.1.2 市場予測
7.2 外傷
7.2.1 市場動向
7.2.2 市場予測
7.3 関節再建
7.3.1 市場動向
7.3.2 市場予測
7.4 足および足首
7.4.1 市場動向
7.4.2 市場予測
7.5 歯科用骨移植
7.5.1 市場動向
7.5.2 市場予測
7.6 頭蓋顎顔面
7.6.1 市場動向
7.6.2 市場予測
7.7 その他
7.7.1 市場動向
7.7.2 市場予測
8 エンドユーザー別市場
8.1 病院
8.1.1 市場動向
8.1.2 市場予測
8.2 外科センター
8.2.1 市場動向
8.2.2 市場予測
8.3 診療所
8.3.1 市場動向
8.3.2 市場予測
8.4 その他
8.4.1 市場動向
8.4.2 市場予測
9 地域別市場内訳
9.1 北米
9.1.1 市場動向
9.1.2 市場予測
9.2 ヨーロッパ
9.2.1 市場動向
9.2.2 市場予測
9.3 アジア太平洋
9.3.1 市場動向
9.3.2 市場予測
9.4 中東およびアフリカ
9.4.1 市場動向
9.4.2 市場予測
9.5 ラテンアメリカ
9.5.1 市場動向
9.5.2 市場予測
10 SWOT分析
10.1 概要
10.2 強み
10.3 弱み
10.4 機会
10.5 脅威
11 バリューチェーン分析
12 ポーターのファイブフォース分析
12.1 概要
12.2 買い手の交渉力
12.3 売り手の交渉力
12.4 競争の度合い
12.5 新規参入の脅威
12.6 代替品の脅威
13 価格分析
14 競合状況
14.1 市場構造
14.2 主要企業
14.3 主要企業のプロフィール
Zimmer Biomet Dental
DePuy Synthes
Wright Medical Technology
Medtronic Plc
Stryker Corporation
NuVasive Inc
Arthrex Inc
Integra LifeSciences
Baxter International Inc
Musculoskeletal Transplant Foundation
Bacterin International Holdings
SeaSpine
LifeNet Health
Bone Graft and Substitutes Market Analysis:
Market Growth and Size: The market is witnessing stable growth, driven by the rising demand for orthopedic surgeries and advanced bone graft materials, growing geriatric population, rapid technological advancements, and the increasing incidences of bone-related diseases.
Major Market Drivers: Key drivers influencing the market growth include the rising prevalence of bone and joint disorders, advancements in graft materials, increasing number of orthopedic surgeries, growing preference for minimally invasive surgeries (MIS), and implementation of supportive government initiatives.
Key Market Trends: The key market trends involve the ongoing shift towards using synthetic and biocompatible bone graft substitutes and cell-based matrices due to concerns over disease transmission and consistency in traditional grafts. Additionally, the integration of three-dimensional (3D) printing and nanotechnology in graft manufacturing is bolstering the market growth.
Geographical Trends: North America leads the market due to its advanced healthcare infrastructure, high healthcare spending, and the presence of major key market players. Other regions are also showing significant growth, fueled by increasing healthcare expenditure and improvements in healthcare infrastructure.
Competitive Landscape: The market is characterized by the active involvement of key players who are focusing on research and development (R&D), strategic mergers and acquisitions, and global expansion. Furthermore, companies are investing in marketing and educational efforts to increase product awareness and adoption.
Challenges and Opportunities: The market faces various challenges, such as stringent regulatory environments, high cost of advanced graft materials, and ethical concerns regarding the use of certain grafts. However, growing demand for innovative and effective bone graft solutions in emerging markets and the development of personalized and advanced graft materials are creating new opportunities for the market growth.
Bone Graft and Substitutes Market Trends:
Increasing incidence of bone and joint disorders
The rising prevalence of bone and joint disorders, such as osteoporosis, osteoarthritis, and spinal disorders, is one of the major factors boosting the market growth. In line with this, the growing demand for effective treatment options, including bone grafts and substitutes, as they are crucial in surgeries related to spinal fusions, joint reconstruction, and trauma surgeries, is favoring the market growth. Moreover, the increasing geriatric population across the globe, who are susceptible to joint disorders is propelling the market growth. Along with this, the rising incidence of bone and joint disorders due to lifestyle factors, including reduced physical activity and poor nutrition, is also contributing to the market growth. Besides this, the heightened demand for bone grafts and substitutes due to the growing awareness and diagnosis rates of various conditions is acting as a growth-inducing factor.
Rapid technological advancements
The rising advancements in biomaterials that are used for bone grafting are major factors bolstering the market growth. In line with this, the development of synthetic and biocompatible materials, such as calcium phosphate ceramics, bioactive glasses, and various polymers that efficiently aid in bone regeneration and healing, is providing a thrust to the market growth. They offer several advantages, such as reduced risk of disease transmission, consistent quality, and the ability to tailor the material properties to specific clinical needs. Moreover, the widespread integration of advanced technologies like three-dimensional (3D) printing that enable the creation of customized grafts that perfectly match the patient's anatomy while improving surgical outcomes is anticipated to drive the market growth. Besides this, the rapid utilization of nanotechnology in bone grafting materials to mimic the natural bone structure more closely, offering improved osteoconduction and biocompatibility, is stimulating the market growth.
Increasing cases of orthopedic surgeries
The increasing number of orthopedic surgeries performed across the globe due to the rising prevalence of sports injuries, accidents, and the growing geriatric population, is a major factor propelling the market growth. Moreover, the increasing utilization of bone grafts and substitutes in procedures such as spinal fusion, limb salvage surgeries, and reconstructive surgeries is creating a positive outlook for the market growth. Along with this, the escalation in orthopedic surgeries due to the rising prevalence of chronic diseases that affect the musculoskeletal system, like diabetes and rheumatoid arthritis, is bolstering the market growth. Apart from this, the heightened diversification of orthopedic procedures, including the advent of new surgical techniques and the expansion of surgical indications, are contributing to the market growth.
Growing preference for minimally invasive (MI) surgical procedures
The increasing preference for minimally invasive surgeries (MIS) among patients and surgeons due to its various benefits, such as reduced surgical trauma, shorter hospital stays, and faster recovery times, is acting as a growth-inducing factor. Moreover, the development and adoption of bone grafting products suitable for minimally invasive applications, propelling the demand for allografts, demineralized bone matrices, and synthetic grafts, is providing a considerable boost to the market growth. Additionally, rapid advancements in surgical instruments and imaging technologies, which allow for more precise and efficient surgeries, are acting as a growth-inducing factor. In line with this, the development of specialized MIS tools that are compatible with bone graft materials to enhance the efficiency and success rates of the procedures is fostering the market growth.
Implementation of supportive government initiatives
The increasing support by government bodies and healthcare organizations for research and development (R&D) in bone grafts and substitutes is a major factor fueling the market growth. It includes funding, grants, and facilitation of regulatory approvals for new and advanced products, aiding the development of innovative bone grafting solutions. Moreover, the growing collaboration between research institutions and industry players, leading to technological innovations and improved clinical outcomes, is providing an impetus to the market growth. In line with this, the rising public-private partnerships that provide a platform for clinical trials and studies to validate the efficacy and safety of new products are enhancing the market growth. Apart from this, the imposition of policies that streamline the approval process for new products, significantly reducing the time and cost associated with developing new products, is contributing to the market growth.
Bone Graft and Substitutes Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global and regional levels for 2025-2033. Our report has categorized the market based on material type, application, and end user.
Breakup by Material Type:
Allografts
Machined Allografts
Demineralized Bone Matrix (DBMs)
Bone Graft Substitutes
Bone Morphogenic Proteins (BMPs)
Synthetic Bone Grafts
Cell-based Matrices
Others
Allografts accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the material type. This includes allografts (machined allografts and demineralized bone matrix (DBMs)), bone graft substitutes (bone morphogenic proteins (BMPs) and synthetic bone grafts), cell-based matrices, and others. According to the report, allografts represented the largest segment.
Allografts hold the largest market share as they are extensively used in various orthopedic procedures due to their osteoconductive and osteoinductive properties. They are favored in complex surgeries, such as spinal fusion, due to their ability to mimic natural bone structure and promote new bone growth. Moreover, allografts are available in various forms, including fresh, freeze-dried, and demineralized bone matrices, catering to a wide range of clinical needs. Besides this, the rising preference for allografts due to their effectiveness in facilitating bone healing, thus reducing the risk of patient morbidity associated with autograft harvesting is acting as growth-inducing factors.
Bone graft substitutes comprise synthetic materials or biologically derived products that are used as alternatives to traditional bone grafts. They include ceramics, polymers, and composite materials designed to provide a scaffold for bone growth and reduce the need for autografts or allografts. Moreover, their consistent quality and the elimination of risks related to disease transmission or immune rejection are enhancing the market growth.
Cell-based matrices involve the use of living cells combined with scaffolding materials to promote bone regeneration. They are seeded with a patient's cells or donor cells, making them highly biocompatible and effective in enhancing the bone healing process. Moreover, the widespread integration of stem cell technology and tissue engineering in cell-based matrices is driving the market growth.
Breakup by Application:
Spinal Fusion
Trauma
Joint Reconstruction
Foot and Ankle
Dental Bone Grafting
Craniomaxillofacial
Others
Spinal fusion holds the largest share in the industry
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes spinal fusion, trauma, joint reconstruction, foot and ankle, dental bone grafting, craniomaxillofacial, and others. According to the report, spinal fusion accounted for the largest market share.
Spinal fusion represents the largest segment in the market, driven by the increasing prevalence of spinal disorders, such as degenerative disc disease, scoliosis, and spinal stenosis. Bone grafts and substitutes are essential in spinal fusion surgeries for facilitating the fusion of two or more vertebrae to stabilize the spine and alleviate pain. Moreover, the effectiveness of bone grafts in promoting bone growth and healing is creating a positive outlook for the market growth. Besides this, the increasing utilization of demineralized bone matrices, along with synthetic bone graft substitutes in spinal fusion surgeries, due to their osteoconductive properties and ability to integrate with the patient's bone, is supporting the market growth.
Trauma surgeries involve the use of bone grafts and substitutes in the treatment of fractures and bone defects resulting from accidents, injuries, or surgeries. They help in supporting bone healing, especially in cases of complex fractures or where bone loss has occurred. Moreover, the continuous development of high-strength and biocompatible graft materials that provide structural support and enhance the natural healing process, is fueling the market growth.
Joint reconstruction surgeries, such as hip or knee replacements, often require bone grafts for better integration of implants and restoration of joint function. They help fill bone voids and promote bone ingrowth around prosthetic components to ensure the stability and longevity of the implants. Furthermore, the increasing incidence of joint disorders and the growing geriatric population are contributing to the market growth.
In foot and ankle surgeries, bone grafts are used for reconstructive procedures, treating deformities, and healing of fractures. Moreover, the growing demand for specific types of grafts that can conform to the complex anatomy of the foot and ankle, providing structural support and promoting bone regeneration, is boosting the market growth. Besides this, the rising number of sports-related injuries and conditions like arthritis are favoring the market growth.
Dental bone grafting utilizes grafts to augment the jawbone and support dental implants, especially in cases of bone loss due to periodontal disease or tooth extraction. Along with this, the growing utilization of dental bone grafts owing to the increasing popularity of dental implants for missing teeth is stimulating the market growth. Besides this, rapid advancements in graft materials that ensure better integration and stability of the implants are enhancing the market growth.
Craniomaxillofacial involves the application of bone grafts in surgeries related to the skull, face, and jaws. They are essential in reconstructive surgeries, trauma recovery, and congenital disability repairs. Moreover, the development of customized graft solutions that can adapt to the complex geometries of facial bones, ensuring functional and aesthetic outcomes, is propelling the market growth.
Breakup by End User:
Hospitals
Surgical Centres
Clinics
Others
Hospitals represents the leading market segment
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, surgical centres, clinics, and others. According to the report, hospitals represented the largest segment.
Hospitals represent the largest segment due to their comprehensive healthcare services, including advanced surgical procedures that require bone grafts and substitutes. Moreover, they are equipped with advanced facilities and a wide range of medical specialties, making them the preferred choice for complex surgeries, such as spinal fusion, joint reconstruction, and trauma-related procedures. Besides this, the widespread availability of skilled surgeons, multidisciplinary teams, and advanced post-operative care in hospitals is contributing to the market growth. Additionally, hospitals have the infrastructure to support the storage and handling of various types of bone grafts, including those that require specific storage conditions.
Surgical centres are known for procedures that require bone grafting but do not necessitate the extensive resources of a hospital. They include certain types of dental bone grafting, minor joint repairs, and some cosmetic and reconstructive surgeries. Moreover, the heightened focus on minimally invasive (MI) techniques, which reduce patient recovery time and resource utilization, is boosting the market growth.
Clinics include specialized orthopedic and dental clinics that cater to specific procedures that involve bone grafting, such as dental implant placement or minor orthopedic corrections. They provide targeted and specialized care in a more personalized and accessible setting. Additionally, the rising growth in specialized clinics, along with advancements in outpatient surgical techniques, is bolstering the market growth.
Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
North America leads the market, accounting for the largest bone graft and substitutes market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America holds the largest market share, due to the high prevalence of bone-related disorders, advanced healthcare infrastructure, and the presence of key market players in the region. In line with this, the increasing number of orthopedic procedures, including spinal fusion and joint reconstruction surgeries, driving the demand for bone grafts and substitutes, is boosting the market growth. Additionally, the rising medical research and innovation, with substantial investments in developing advanced graft materials and surgical techniques, is fueling the market growth. Along with this, the increasing healthcare expenditure and the presence of well-established healthcare systems is contributing to the market growth.
The Europe’s market for bone graft and substitutes is driven by factors, such as the growing geriatric population, increasing incidences of osteoporosis and other bone-related conditions, and the adoption of advanced medical technologies. Along with this, the well-developed healthcare system and the presence of some of the leading players in the medical device industry, is fueling the market growth.
The Asia Pacific region is experiencing rapid growth in the market, attributed to the increasing healthcare expenditure, growing awareness of advanced medical treatments, and an expanding geriatric population. Moreover, the rising number of orthopedic procedures due to the growing middle class and improvements in healthcare infrastructure, is also acting as growth-inducing factors.
In Latin America, the market for bone graft and substitutes is growing steadily, driven by the gradual improvement in healthcare infrastructure and increasing accessibility to advanced medical treatments. Besides this, the increasing prevalence of chronic diseases that affect bone health, coupled with a growing focus on healthcare modernization, is strengthening the market growth.
The market in the Middle East and Africa is evolving due to the improving healthcare infrastructure and increasing government initiatives to modernize healthcare services. Along with this, the widespread adoption of advanced medical technologies, including bone grafts and substitutes, in the region is creating a positive outlook for the market growth.
Leading Key Players in the Bone Graft and Substitutes Industry:
The major players are engaged in various strategic initiatives to strengthen their market position and respond to the evolving medical needs in orthopedics. They are investing in research and development (R&D) to innovate and improve their product offerings by focusing on developing advanced materials that are more biocompatible, osteoconductive, and osteoinductive. Besides this, the leading firms are emphasizing creating synthetic and hybrid grafts that combine the benefits of natural bone tissue with the versatility and safety of synthetic materials. Moreover, they are expanding their reach through mergers and acquisitions, partnerships with healthcare providers, and collaborations with research institutions to enhance their technological capabilities and market access.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
Zimmer Biomet Dental
DePuy Synthes
Wright Medical Technology
Medtronic Plc.
Stryker Corporation
NuVasive Inc.
Arthrex Inc.
Integra LifeSciences
Baxter International Inc.
Musculoskeletal Transplant Foundation
Bacterin International Holdings
SeaSpine
LifeNet Health
Key Questions Answered in This Report
1. How big is the global bone graft and substitutes market?
2. What is the expected growth rate of the global bone graft and substitutes market during 2025-2033?
3. What are the key factors driving the global bone graft and substitutes market?
4. What has been the impact of COVID-19 on the global bone graft and substitutes market?
5. What is the breakup of the global bone graft and substitutes market based on the material type?
6. What is the breakup of the global bone graft and substitutes market based on the application?
7. What is the breakup of the global bone graft and substitutes market based on the end user?
8. What are the key regions in the global bone graft and substitutes market?
9. Who are the key players/companies in the global bone graft and substitutes market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Bone Graft and Substitute Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Material Type
5.5 Market Breakup by Application
5.6 Market Breakup by End User
5.7 Market Breakup by Region
5.8 Market Forecast
6 Market Breakup by Material Type
6.1 Allografts
6.1.1 Market Trends
6.1.2 Market Breakup By Type
6.1.2.1 Machined Allografts
6.1.2.1.1 Market Trends
6.1.2.1.2 Market Forecast
6.1.2.2 Demineralized Bone Matrix (DBMs)
6.1.2.2.1 Market Trends
6.1.2.2.2 Market Forecast
6.1.3 Market Forecast
6.2 Bone Graft Substitutes
6.2.1 Market Trends
6.2.2 Market Breakup By Type
6.2.2.1 Bone Morphogenic Proteins (BMPs)
6.2.2.1.1 Market Trends
6.2.2.1.2 Market Forecast
6.1.2.2 Synthetic Bone Grafts
6.2.2.2.1 Market Trends
6.2.2.2.2 Market Forecast
6.2.3 Market Forecast
6.3 Cell-based Matrices
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Application
7.1 Spinal Fusion
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Trauma
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Joint Reconstruction
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Foot and Ankle
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Dental Bone Grafting
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Craniomaxillofacial
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Others
7.7.1 Market Trends
7.7.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Surgical Centres
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Clinics
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Europe
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Asia Pacific
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Middle East and Africa
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Latin America
9.5.1 Market Trends
9.5.2 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Zimmer Biomet Dental
14.3.2 DePuy Synthes
14.3.3 Wright Medical Technology
14.3.4 Medtronic Plc.
14.3.5 Stryker Corporation
14.3.6 NuVasive Inc.
14.3.7 Arthrex Inc.
14.3.8 Integra LifeSciences
14.3.9 Baxter International Inc.
14.3.10 Musculoskeletal Transplant Foundation
14.3.11 Bacterin International Holdings
14.3.12 SeaSpine
14.3.13 LifeNet Health
*** 骨移植＆代替品の世界市場に関するよくある質問(FAQ) ***
・骨移植＆代替品の世界市場規模は？
→IMARC社は2024年の骨移植＆代替品の世界市場規模を34億米ドルと推定しています。
・骨移植＆代替品の世界市場予測は？
→IMARC社は2033年の骨移植＆代替品の世界市場規模を52億米ドルと予測しています。
・骨移植＆代替品市場の成長率は？
→IMARC社は骨移植＆代替品の世界市場が2025年～2033年に年平均5.0%成長すると展望しています。
・世界の骨移植＆代替品市場における主要プレイヤーは？
→「Zimmer Biomet Dental, DePuy Synthes, Wright Medical Technology, Medtronic Plc., Stryker Corporation, NuVasive Inc., Arthrex Inc., Integra LifeSciences, Baxter International Inc., Musculoskeletal Transplant Foundation, Bacterin International Holdings, SeaSpine, LifeNet Healthなど ...」を骨移植＆代替品市場のグローバル主要プレイヤーとして判断しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
